Lung cancer is the most malignant human cancer worldwide, also with the highest incidence
rate. However, small-cell lung cancer (SCLC) accounts for 14% of all lung cancer cases …

Background Radiotherapy is the mainstay of brain metastasis (BM) management. Radiation
necrosis (RN) is a serious complication of radiotherapy. Bevacizumab (BV), an anti-vascular …

Background: Targeted therapy has transformed the outcome for patients with metastatic
renal cell carcinoma. Their efficacy and safety have also been demonstrated in brain …

With the advancement of imaging technology, systemic disease control rate and survival
rate, the morbidity of brain metastases (BMs) from non-small cell lung cancer (NSCLC) has …

Background The treatment for brain metastases in small cell lung cancer (SCLC) is still
controversial. The purpose of this study was to compare different brain radiotherapy …

Background Brain metastases (BM) are a common complication in advanced cancer
patients, and extremely challenging to treat. Consequently, whole brain radiotherapy …

Objectives: Describe the mechanism of stereotactic radiosurgery and explain the differences
from conventional radiotherapy. Identify the types of devices available for stereotactic …

Background Radiation therapy (RT) is the mainstay of brain metastases (BMs), and anti-PD-
1 blockade has led to intracranial responses in non-small cell lung carcinoma (NSCLC) …

Tumor-to-tumor metastasis is a rare clinical phenomenon. Although meningioma is the most
common intracranial recipient of cancer metastasis, only a few cases have been reported …

Background The optimal treatment for multiple brain metastases has been recently
controversially discussed. This study was aimed to explore the feasibility of Hippocampus …